Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $242.7 million versus the consensus estimate of $234.47 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.